CAS RN: 912773-22-9
6-Bromo-pyrazolo[1,5-a]py…
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20260206
100mg / 250mg / 500mg / 1g / 5g / 25g
Confirm by inquiry
Shanghai 5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 912773-22-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Shanghai
Inquiry
912773-22-9 / 6-bromopyrazolo[1,5-a]pyrimidine-3-carboxylic acid
Standard CAS: 912773-22-9
Multi CAS: No
Basic Information
copy
CAS
912773-22-9 copy
Multi CAS
No copy
Molecular Formula
BC7H4O2Rn3 copy
Molecular Weight
242.030000 copy
Exact Mass
240.948690 copy
InChI
InChI=1S/C7H4BrN3O2/c8-4-1-9-6-5(7(12)13)2-10-11(6)3-4/h1-3H,(H,12,13) copy
InChIKey
OKAAFIKHHROVHN-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Aromatic heavy atom count
9 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
H-bond donors
1 copy
Molar refractivity
47.65 copy
TPSA
67.49 copy
LogP / Solubility
WLOGP
1.19 copy
MLOGP
1.05 copy
XLogP3
0.5 copy
Consensus LogP
0.91 copy
Log S (ESOL)
-2.54 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.4 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.34 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.35 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy